Close

FibroGen (FGEN) Tops Q2 EPS by 14c

August 8, 2022 4:58 PM EDT

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($0.78), $0.14 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $29.8 million versus the consensus estimate of $36.16 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings